Evidence map›Paper›PMID 28182669›Full record

ArticlePloS one2017

A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.

Kai Gao, Anel Tankovic, Yujia Zhang, Hirofumi Kusumoto, Jin Zhang, Wenjuan Chen, Wenshu XiangWei, Gil H Shaulsky, Chun Hu, Stephen F Traynelis and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. ZniScience · 2022
    Article
  13. Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Article
  16. Protein quality control ofFrontiers in cellular neuroscience · 2022
    Review
  17. Review
  18. Neurology international · 2021
    Article
  19. Article
  20. Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy.Frontiers in molecular neuroscience · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Kai GaoDepartment of Pediatrics and Pediatric Epilepsy Center, Peking University First Hospital, Beijing, China.
Anel TankovicDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA, United States of America.
Yujia ZhangDepartment of Pediatrics and Pediatric Epilepsy Center, Peking University First Hospital, Beijing, China.
Hirofumi KusumotoDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA, United States of America.
Jin ZhangDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA, United States of America.
Wenjuan ChenDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA, United States of America.
Wenshu XiangWeiDepartment of Pediatrics and Pediatric Epilepsy Center, Peking University First Hospital, Beijing, China.
Gil H ShaulskyDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA, United States of America.
Chun HuDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA, United States of America.
Stephen F TraynelisDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA, United States of America.
Hongjie YuanDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA, United States of America.
Yuwu JiangDepartment of Pediatrics and Pediatric Epilepsy Center, Peking University First Hospital, Beijing, China.
Emory University · USPeking University · CN

Funding

Control of Glutamate Receptor FunctionR01NS036654 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 1998 to 2018
$3.7M
Mechanism of Action of Novel Subunit-Selective NMDA Receptor ModulatorsR01NS065371 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 2009 to 2018
$3.4M
NMDAR Mutations & Neurodevelopmental Disorder: from Mechanism to Targeted TherapyR01HD082373 · NICHD · EMORY UNIVERSITY · PI YUAN, HONGJIE · 2015 to 2025
$3.3M
Functional effects of ion channel mutations found via exome sequencingR24NS092989 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 2016 to 2019
$1.1M
NICHD NIH HHS R01 HD082373NINDS NIH HHS R01 NS036654NINDS NIH HHS R01 NS065371NINDS NIH HHS R24 NS092989
6 · The paper itself

Abstract

objectiveN-methyl-D-aspartate receptors (NMDAR) subunit GRIN2A/GluN2A mutations have been identified in patients with various neurological diseases, such as epilepsy and intellectual disability / developmental delay (ID/DD). In this study, we investigated the phenotype and underlying molecular mechanism of a GRIN2A missense mutation identified by next generation sequencing on idiopathic focal epilepsy using in vitro electrophysiology.

methodsGenomic DNA of patients with epilepsy and ID/DD were sequenced by targeted next-generation sequencing within 300 genes related to epilepsy and ID/DD. The effects of one missense GRIN2A mutation on NMDAR function were evaluated by two-electrode voltage clamp current recordings and whole cell voltage clamp current recordings.

resultsWe identified one de novo missense GRIN2A mutation (Asp731Asn, GluN2A(D731N)) in a child with unexplained epilepsy and DD. The D731N mutation is located in a portion of the agonist-binding domain (ABD) in the GluN2A subunit, which is the binding pocket for agonist glutamate. This residue in the ABD is conserved among vertebrate species and all other NMDAR subunits, suggesting an important role in receptor function. The proband shows developmental delay as well as EEG-confirmed seizure activity. Functional analyses reveal that the GluN2A(D731N) mutation decreases glutamate potency by over 3,000-fold, reduces amplitude of current response, shortens synaptic-like response time course, and decreases channel open probability, while enhancing sensitivity to negative allosteric modulators, including extracellular proton and zinc inhibition. The combined effects reduce NMDAR function. SIGNIFICANCE: We identified a de novo missense mutation in the GRIN2A gene in a patient with childhood focal epilepsy and acquired epileptic aphasia. The mutant decreases NMDAR activation suggesting NMDAR hypofunction may contribute to the epilepsy pathogenesis.

Indexed as

ElectroencephalographyEpilepsies, PartialLandau-Kleffner SyndromeMutation, MissenseReceptors, N-Methyl-D-AspartateAmino Acid SubstitutionFemaleHEK293 CellsHigh-Throughput Nucleotide SequencingHumansMaleMembrane PotentialsReceptors, N-Methyl-D-Aspartate

Identifiers

PMID28182669
PMCPMC5300259
OpenAlexW2587599345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.